Intrathecal baclofen therapy for severe spasticity in an adult with tethered cord syndrome: a case report

J Med Case Rep. 2021 Sep 2;15(1):442. doi: 10.1186/s13256-021-03049-0.

Abstract

Background: Patients with tethered cord syndrome often suffer severe spasticity. To the best of our knowledge, intrathecal baclofen (ITB) therapy in a patient with tethered cord syndrome has not been reported previously. We describe a case in which ITB therapy was useful for treating severe spasticity in an adult with tethered cord syndrome.

Case presentation: We present the case of a 50-year-old Japanese woman with tethered cord syndrome and related conditions suffering from severe spasticity and pain in the lower limbs. She was born with a lumbosacral myelomeningocele, which was closed in the neonatal period. For 4-5 years before this presentation, spasticity in the lower limbs had been exacerbated without any obvious cause. She received rehabilitation and pharmacotherapy from a local doctor, but symptoms were unimproved, and her previous doctor referred her to this department. A test with 50 μg of intrathecally delivered baclofen showed total relief of spasticity and pain, so a pump was implanted for continuous baclofen delivery. During 24 months of follow-up, spasticity has remained under excellent control with baclofen at 38.5-41.0 μg/day.

Conclusions: ITB therapy proved extremely effective in this adult with severe spasticity from tethered code syndrome.

Keywords: Baclofen; Intrathecal infusion; Spasticity; Tethered cord syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Baclofen / therapeutic use
  • Female
  • Humans
  • Infant, Newborn
  • Infusion Pumps, Implantable
  • Injections, Spinal
  • Middle Aged
  • Muscle Relaxants, Central* / therapeutic use
  • Muscle Spasticity / drug therapy
  • Muscle Spasticity / etiology
  • Neural Tube Defects* / complications
  • Neural Tube Defects* / drug therapy

Substances

  • Muscle Relaxants, Central
  • Baclofen